Low IgE is a useful tool to identify STAT3 gain-of-functionmMutations.

dc.contributor.author	Johnson, MB
dc.contributor.author	Flanagan, SE
dc.contributor.author	Martins, TB
dc.contributor.author	Hill, HR
dc.contributor.author	Hattersley, AT
dc.contributor.author	McDonald, TJ
dc.date.accessioned	2017-01-31T15:30:39Z
dc.date.issued	2016-11
dc.description.abstract	Letter to the editor	en_GB
dc.description.sponsorship	This work was supported by the Wellcome Trust. SF has a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant Number 105636/Z/14/Z).	en_GB
dc.identifier.citation	Vol. 62, pp. 1536 - 1538	en_GB
dc.identifier.doi	10.1373/clinchem.2016.263624
dc.identifier.other	clinchem.2016.263624
dc.identifier.uri	http://hdl.handle.net/10871/25491
dc.language.iso	en	en_GB
dc.publisher	American Association for Clinical Chemistry	en_GB
dc.relation.url	https://www.ncbi.nlm.nih.gov/pubmed/27608644	en_GB
dc.rights.embargoreason	Publisher policy	en_GB
dc.title	Low IgE is a useful tool to identify STAT3 gain-of-functionmMutations.	en_GB
dc.type	Article	en_GB
dc.identifier.issn	1530-8561
exeter.place-of-publication	United States	en_GB
dc.description	This is the author accepted manuscript. The final version is available from the publisher via the DOI in this record.	en_GB
dc.identifier.journal	Clinical Chemistry	en_GB
dc.identifier.pmid	27608644